Peer-led Support Program for Refugee Families
Trial Summary
What is the purpose of this trial?
The proposed study draws on prior research to evaluate the feasibility, acceptability and explore preliminary effectiveness of Coffee and Family Education and Support, Version (CAFES2) using a pilot randomized type 1 hybrid effectiveness-implementation design. CAFES2 is a peer-led family and social strengthening multiple family group intervention that is designed to respond to multi-level needs of refugee families. Results of the trial will contribute to the emerging evidence base on family-based mental health interventions for refugee and newcomer communities. The trial will also generate new insights regarding implementation strategies needed to promote successful delivery of services by peer providers and the unique role of human-centered design practices for adaptation of mental health and psychosocial interventions.
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications. It seems focused on family support and mental health, so it's best to ask the trial organizers for more details.
What data supports the effectiveness of the treatment CAFES2 for refugee families?
Research on similar family-based support programs for refugees, like the Family Strengthening Intervention and TAFES, shows that these programs can improve family communication, social support, and mental health outcomes. These findings suggest that peer-led support and education, as in CAFES2, may also be beneficial for refugee families.12345
Is the Peer-led Support Program for Refugee Families safe for participants?
How is the CAFES2 treatment different from other treatments for refugee families?
CAFES2 is unique because it is a peer-led support program specifically designed for refugee families, focusing on family education and support. Unlike traditional treatments that may rely on professional clinicians, this program emphasizes the involvement of trained family peers who share similar experiences, making it more relatable and accessible for participants.910111213
Research Team
Mary Bunn, PhD
Principal Investigator
University of Illinois Chicago
Eligibility Criteria
This trial is for resettled refugee families with at least one school-aged child (12-17 years old) living with them. Participants should be between 18-45 years old and have arrived in the U.S. as refugees. At least one family member must show moderate emotional distress to qualify.Inclusion Criteria
Exclusion Criteria
Trial Timeline
Screening
Participants are screened for eligibility to participate in the trial
Adaptation
Adaptation of the CAFES model for delivery by peers using implementation science and human-centered design methods
Treatment
Participants receive a home visit and participate in six multiple family group sessions
Follow-up
Participants are monitored for changes in mental health and social support outcomes
Treatment Details
Interventions
- CAFES2 (Behavioral Intervention)
Find a Clinic Near You
Who Is Running the Clinical Trial?
University of Illinois at Chicago
Lead Sponsor
Mark I. Rosenblatt
University of Illinois at Chicago
Chief Executive Officer
MD, PhD, MBA, MHA
Jon Radosta
University of Illinois at Chicago
Chief Medical Officer since 2023
MD
National Institute of Mental Health (NIMH)
Collaborator
Dr. Joshua A. Gordon
National Institute of Mental Health (NIMH)
Chief Executive Officer since 2016
MD, PhD
Dr. Shelli Avenevoli
National Institute of Mental Health (NIMH)
Chief Medical Officer
PhD